Plain-English translation of NCT02682667 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →Researchers at the National Cancer Institute are collecting blood, tissue, and other biological samples from people with cancer, precancerous conditions, or conditions that increase cancer risk. These samples will be studied in the laboratory to help scientists understand how to better treat cancer using immunotherapy — treatments that help the body's own immune system fight cancer.
Immunotherapy is a promising new approach to treating many types of cancer, but researchers need to study real patient samples to develop and improve these treatments. This trial creates a biobank of samples that will support multiple cancer research studies.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic to have samples collected, which may include blood draws, tissue biopsies, bone marrow samples, or other bodily fluids depending on what researchers need. No experimental medications or treatments will be given as part of this study — it is purely for sample collection and laboratory research. Some participants may be asked to return for additional sample collections over time.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United States
Enrollment target
~500 participants
Started
April 2016
Primary completion
December 2030
Age range
18 Years – 120 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Scott M Norberg, D.O.
National Cancer Institute (NCI)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.